Zevra Therapeutics (ZVRA) Return on Assets [ROA] (2015 - 2026)
Zevra Therapeutics (ZVRA) reported Return on Assets [ROA] of 25.32% for Q3 2026, up 11.90 percentage points from 13.42% a year earlier and up 5.27 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics posted Return on Assets [ROA] of 35.96%, up 96.18 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of +153.54 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -60.21% in FY2024 (-28.20 pp), -32.02% in FY2023 (-10.45 pp), -21.57% in FY2022 (-9.70 pp) and -11.87% in FY2021 (+105.70 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -57.08% in Q4 2024 and a high of 44.10% in Q1 2026.
- Year over year, Return on Assets [ROA] has now increased in each of the last six quarters, with an average year-over-year change of +34.77 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2021 (a gain of 107.58 percentage points); the low point was Q3 2024 (a drop of 36.69 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 20.05% (Q2 2026), 44.10% (Q1 2026) and 30.00% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 25.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 25.32% |
| Jun 30, 2026 | 20.05% |
| Mar 31, 2026 | 44.10% |
| Dec 31, 2025 | 30.00% |
| Sep 30, 2025 | 13.42% |
| Jun 30, 2025 | 1.23% |
| Mar 31, 2025 | -52.44% |
| Dec 31, 2024 | -57.08% |
| Sep 30, 2024 | -53.38% |
| Jun 30, 2024 | -45.19% |
| Mar 31, 2024 | -30.56% |
| Dec 31, 2023 | -29.58% |
| Sep 30, 2023 | -16.69% |
| Jun 30, 2023 | -15.70% |
| Mar 31, 2023 | -34.36% |
| Dec 31, 2022 | -22.80% |
| Sep 30, 2022 | -28.90% |
| Jun 30, 2022 | -24.30% |
| Mar 31, 2022 | -0.10% |
| Dec 31, 2021 | -6.33% |
API Access
Zevra Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();